SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-008581
Filing Date
2022-03-31
Accepted
2022-03-31 17:27:23
Documents
87
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1603821
2 ex4-1.htm EX-4.1 18323
3 ex21-1.htm EX-21.1 5993
4 ex23-1.htm EX-23.1 3375
5 ex31-1.htm EX-31.1 18686
6 ex31-2.htm EX-31.2 11642
7 ex32-1.htm EX-32.1 5434
8 image_001.jpg GRAPHIC 2002
9 image_002.jpg GRAPHIC 2702
  Complete submission text file 0001493152-22-008581.txt   7682636

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ghsi-20211231.xsd EX-101.SCH 57933
11 XBRL CALCULATION FILE ghsi-20211231_cal.xml EX-101.CAL 74866
12 XBRL DEFINITION FILE ghsi-20211231_def.xml EX-101.DEF 268004
13 XBRL LABEL FILE ghsi-20211231_lab.xml EX-101.LAB 516841
14 XBRL PRESENTATION FILE ghsi-20211231_pre.xml EX-101.PRE 403298
81 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1120552
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38861 | Film No.: 22794533
SIC: 2834 Pharmaceutical Preparations